UAE launches landmark $60mln initiative to expand accessible education for visually impaired students in Ethiopia
Initiative reinforces the UAE's commitment to inclusive societies and its ongoing support for Ethiopia's efforts to expand educational access for the visually impaired nationwide
Abu Dhabi, United Arab Emirates: Under the directives of UAE President His Highness Sheikh Mohamed bin Zayed Al Nahyan, and in the lead-up to the AU Summit opening today — where advancing development in Africa is a key focus — the UAE announced a landmark USD 60 million (AED 220 million) education initiative in collaboration with the Federal Democratic Republic in Ethiopia.
Launched through the Khalifa Bin Zayed Al Nahyan Foundation – a portfolio entity of Erth Zayed Philanthropies – the initiative will support the construction and development of schools tailored to the educational needs of visually impaired students across Ethiopia.
The initiative reinforces the UAE's commitment to inclusive and sustainable development in Africa and builds on the success of the Sheikha Fatima bint Mubarak School for the Blind in Addis Ababa, which was inaugurated in May 2024.
The agreement was signed by His Excellency Mohamed Haji AlKhoori, Director General of the Khalifa Bin Zayed Al Nahyan Foundation, in the presence of His Excellency Sheikh Shakhboot bin Nahyan Al Nahyan, Minister of State in the Ministry of Foreign Affairs and Trustee of Erth Zayed Philanthropies, along with Her Excellency Mrs Zinash Tayachew, First Lady of the Federal Democratic Republic of Ethiopia, among other dignitaries.
With an estimated 1.2 million visually impaired individuals in Ethiopia, including 332,000 classified as blind, this initiative directly addresses a pressing humanitarian need by reaching rural areas where educational and healthcare services remain limited. Ethiopia also has one of the highest global rates of trachoma, a preventable eye disease that disproportionately affects underserved communities. With the support of the Ethiopian Ministry of Education, the new schools will serve as centres of excellence, integrating cutting-edge assistive technologies, specialised curricula, and tailored vocational programmes to empower visually impaired students with the skills necessary for higher education and workforce integration.
His Highness Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes' Affairs, Chairman of the International Humanitarian and Philanthropic Council, and Chairman of the Board of Trustees of Erth Zayed Philanthropies, said: 'The UAE remains dedicated to supporting people of determination worldwide. A key element is ensuring that visually impaired students in Ethiopia can access inspiring and inclusive learning environments that meet their specialised needs, thereby enabling them to reach their full potential. This initiative represents the shared commitment by the UAE and Ethiopia to ensure that everyone, regardless of the challenges they may face, can thrive in an inclusive and equitable global society.'
His Excellency Sheikh Shakhboot bin Nahyan Al Nahyan, Cabinet Member and Minister of State in the Ministry of Foreign Affairs, said:"The UAE has long recognised that sustainable development and strategic collaboration are the key drivers of lasting change. This initiative reflects our unwavering commitment to uplifting communities, creating economic opportunities, and expanding access to essential services. Our partnership furthers the vision of African states to invest in education as a catalyst for future prosperity, empowering youth to realise their full potential and drive sustainable growth."
Her Excellency Mrs Zinash Tayachew, First Lady of the Federal Democratic Republic of Ethiopia, added, 'We are grateful to the UAE for their continued partnership, which supports our goal of ensuring that every citizen, regardless of their abilities, has access to quality education. Together, our shared commitment will help to create a more inclusive society where every student has the opportunity to succeed."
His Excellency Mohamed Haji AlKhoori, Director General of the Khalifa Bin Zayed Al Nahyan Foundation, said: 'Education is a fundamental right, and every child deserves the opportunity to learn in an environment that supports their unique needs. By strengthening educational systems, we are laying the foundation for a more inclusive and equitable future. This initiative reaffirms the power of global partnerships in driving lasting impact, ensuring that education remains a catalyst for opportunity and empowerment for generations to come.'
Together with the Sheikha Fatima bint Mubarak School for the Blind, the new schools announced today will create a network across Ethiopia to expand access to inclusive education. The UAE's commitment to strengthening Ethiopia's educational infrastructure ensures that every visually impaired child, regardless of socioeconomic background, can thrive in a supportive learning environment that empowers them to contribute to society.
Fikeru Bejo, IT Teacher at the Sheikha Fatima bint Mubarak School for the Blind, said: 'I am inspired by the incredible resilience and determination of our students to overcome challenges, grow in confidence, and achieve their goals. Their progress is a constant reminder of the transformative power of education. Thanks to the generous contribution of the UAE, we have enhanced our facilities, provided specialised training for our teachers, and introduced assistive technology that greatly improves our students' learning experiences.'
He added that this support has equipped students for success and raised the quality of education they can offer. 'Moreover, it has brought a sense of hope and optimism to our students and their families, knowing that they have access to better opportunities and a brighter future.'
Erth Zayed Philanthropies will support cross-sector initiatives to accelerate global progress and empower underserved communities worldwide.
About Erth Zayed Philanthropies
Erth Zayed Philanthropies was established in November 2024 by federal decree to consolidate the UAE's global philanthropic efforts carried out under the patronage of His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the UAE. Headquartered in Abu Dhabi, Erth Zayed Philanthropies upholds the legacy of giving instilled by the Founding Father of the UAE, the late Sheikh Zayed bin Sultan Al Nahyan, and is chaired by His Highness Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes' Affairs and Chairman of the International Humanitarian and Philanthropic Council. Erth Zayed Philanthropies oversees a portfolio of philanthropic foundations and awards across diverse sectors with the aim of delivering transformative impact to communities in need worldwide.
For media queries, please contact:
Edelman
Raneem Khatib
ErthZayed@edelman.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
6 hours ago
- Gulf Today
Artificial intelligence tools take care of the elderly in Sharjah
The Emirate of Sharjah continues its pioneering efforts to reinforce its position as an age-friendly city by adopting artificial intelligence tools and smart care technologies to serve senior citizens within an integrated system based on a humanitarian vision led by His Highness Dr. Sheikh Sultan Bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah. These initiatives reflect the Emirate's commitment to enhancing the quality of life for all segments of society, especially senior citizens. The goal is to create an environment that respects their needs and honours their experiences. Senior Citizens Services Forum 2024: Strategic recommendations In line with this approach, the Senior Citizens Services Forum, under the theme 'Artificial Intelligence in the Service of the Elderly,' held in 2024, formed an important milestone in shaping the future technological landscape in the field of elderly care. Organised by the Sharjah Social Services Department, the forum concluded with a set of strategic recommendations to increase the application of smart technologies in elderly care. The most notable recommendations included building effective partnerships with the private sector to launch specialised technical and training programmes targeting this group, and involving the elderly in decision-making by forming advisory committees that represent their voice and express their actual needs. A panel discussion on AI for the elderly under way. Other recommendations also covered expanding the use of assistive tools in providing healthcare services and daily follow-up. They proposed developing integrated digital platforms linking healthcare and social service providers. This would facilitate safer and easier access to medical and psychological support, as well as remote consultations. Smart platforms facilitating access to services As a continuation of this approach, the Emirate of Sharjah has developed several digital platforms that make services more accessible and support the independence of the senior citizens within a fully integrated smart environment. Within this framework, the Sharjah Social Services Department launched the 'Virtual Social Adviser' platform, a smart tool supported by artificial intelligence that allows the elderly to communicate with social and healthcare service providers from their homes, via interactive audio and video channels. In addition, the 'Virtual Companion' service was launched, relying on smart screens inside the homes of the elderly, enabling them to have daily communication with nursing, psychological, and social support teams to reduce isolation and enhance mental health. Innovative and supportive smart tools Alongside interactive platforms, a set of innovative smart tools have been employed to support the daily lifestyles of the elderly and achieve the highest levels of safety and comfort at home. The 'Limb' application was also presented, an interactive digital rehabilitation exercise tool that allows specialists to design digital treatment programmes and monitor performance remotely, improving the effectiveness of home care and reducing the need for travel. Comprehensive field services Other than digital solutions, Sharjah places great importance on field services that reach the homes of senior citizens, within a mobile and integrated care system. These digital initiatives have been integrated with different field services such as mobile medical clinics, which visit the homes of the elderly to provide periodic examinations and diagnostic services, alongside home nursing that provides healthcare and delivers medicines for chronic cases. The 'Mishwar' service contributes to transporting the elderly and people with disabilities to health centres, while the 'Ijaba' service, since its launch in 2022, has enabled the completion of official transactions for home care centre beneficiaries, such as renewing official documents without the need to leave home. Active ageing and community participation The Emirate's efforts are not limited to healthcare alone but extend to aspects of social and cultural interaction, within an integrated vision to promote the concept of active ageing and community participation. Sharjah's social policies work to enhance this concept by engaging the elderly in cultural, social, and sports activities. These are supported by artificial intelligence technologies specifically designed to suit their abilities. The Emirate also provides digital training programmes to improve their technical skills, empowering them and increasing their interaction with electronic services. Towards a smart and safe environment for the elderly These initiatives create a sustainable system that embodies Sharjah's commitment to building a smart and safe environment that preserves the dignity of senior citizens and ensures them a high quality of life at every stage. Sharjah's initiatives represent an integrated commitment to building a smart and safe environment for senior citizens, combining technology and care, granting this group a sense of independence and appreciation. Between the implemented digital solutions and future initiatives under study, the Emirate presents an advanced model of social and humanitarian care in the digital age.
Gulf Today
3 days ago
- Gulf Today
UK's Royal Marsden Cancer Charity hails Sheikha Jawaher's role
The Royal Marsden Cancer Charity, which supports the work of The Royal Marsden, has commended the significant support of Her Highness Sheikha Jawaher Bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah and Founder/Royal Patron of the Friends of Cancer Patients (FoCP). Its annual report highlighted her contributions to advancing cancer research, particularly through initiatives over the past five years that have accelerated progress at the Sharjah Clinical Genomics Laboratory within the National Institute for Health and Care Research (NIHR) Centre for Molecular Pathology (CMP), housed within The Royal Marsden in the UK. These efforts have greatly enhanced faster delivery of precise diagnoses and cutting-edge personalised treatments for patients. The report underscored that Her Highness's support has empowered the lab's scientific team to fast-track diagnostics and treatments, bringing hope to thousands of patients. This was achieved through the introduction of state-of-the art facilities to the Sharjah Clinical Genomics Laboratory, including the UK's first robotic genome testing facility; and bringing together world experts in molecular pathology, bioinformatics, translational research. A humanitarian grant has been driving rapid progress The Sharjah Laboratory was launched in 2018 as a humanitarian initiative by Her Highness Sheikha Jawaher Al Qasimi, who donated £500,000 to support its establishment within the CMP at The Royal Marsden in the UK. This donation reflects Her Highness's strong belief that investing in scientific research is foundational in the fight against cancer and that such research can make a genuine global impact, benefiting patients far beyond the institution itself. Founded in 1851, The Royal Marsden in London is the world's first and most renowned cancer centre. Founded in 1851, The Royal Marsden in London is the world's first and most renowned cancer centre. It specialises in the diagnosis, treatment, and research of all types of cancer, with a highly experienced medical team and a dedicated department for paediatric and adolescent care. The hospital serves more than 50,000 patients annually and works in close collaboration with its academic partner, The Institute of Cancer Research, London, cementing its position as a global leader in cancer treatment innovation. Recent advancements raise cancer care Recent advancements at the CMP are enhancing cancer care and were reflected in a comprehensive report. The 'Marsden360' service, developed in partnership with Guardant Health, uses liquid biopsy (a blood test for cancer) to identify the genetic changes in DNA, allowing patients to be matched to targeted treatments. The testing was offered as part of an NHS England national study for patients with suspected late-stage lung cancer, as well as providing a commissioned NHS ctDNA service to guide treatment decisions for eligible patients with suspected late-stage breast cancer. The report also noted the Sharjah Clinical Genomics Laboratory is on track to become the first facility in the UK to offer fully automated genomic testing, with the capacity to conduct 5,000 tests monthly. This is being achieved through collaboration with Automata, a global biotech company providing robotic automation solutions to the life sciences industry. The advancement has improved early detection of genetic mutations and enabled proactive care for high-risk cancer patients. Cutting-edge technology includes the Nanopore PromethION device for precise long-read DNA sequencing, already analyzing 110 whole genomes to yield new insights for treatment development. The CMP also plays a vital role in key clinical trials like 'ENABLE-NGS', 'PREVAIL', and 'ICED' (targeting leukaemia, lung, and rare cancers), 'SIGNIFIED' (offering annual scans for Li-Fraumeni Syndrome), 'INOVATE' (blood-based monitoring for head/neck cancers), and 'RECUT Plus' (studying radiotherapy resistance). Further amplifying its impact, the lab contributed to over 24 peer-reviewed studies in 2024, presented at major conferences like ESMO and ASCO, exploring molecular profiling to redefine cancer risk and reshape treatment strategies. A UAE humanitarian vision for the world The Sharjah Clinical Genomics Laboratory reflects the UAE's vision of investing in human potential and scientific research, transforming humanitarian efforts into tangible impact in patients' lives. It serves as a prime example of successful collaboration between philanthropy and science, through which Sharjah has become an active partner and contributor to the future of genomic medicine worldwide. The laboratory's success in the UK exemplified the vision and commitment of Her Highness Sheikha Jawaher Al Qasimi commitment to supporting cancer patients. Her Highness's efforts have directly supported several specialised institutions such as Children's Cancer Hospital Egypt 57357, the Children's Cancer Center of Lebanon (CCCL), the National Cancer Institute in Egypt (Sheikha Jawaher Al Qasimi Building), and the Union for International Cancer Control's (UICC) Fund for Childhood Cancer Patients.
Sharjah 24
3 days ago
- Sharjah 24
Royal Marsden hails Jawaher Al Qasimi's role in cancer treatment
The report underscored that Her Highness's support has empowered the lab's scientific team to fast-track diagnostics and treatments, bringing hope to thousands of patients. This was achieved through the introduction of state-of-the art facilities to the Sharjah Clinical Genomics Laboratory; including the UK's first robotic genome testing facility; and bringing together world experts in molecular pathology, bioinformatics, translational research. A humanitarian grant has been driving rapid progress The Sharjah Laboratory was launched in 2018 as a humanitarian initiative by Her Highness Sheikha Jawaher Al Qasimi, who donated £500,000 to support its establishment within the CMP at The Royal Marsden in the UK. This donation reflects Her Highness's strong belief that investing in scientific research is foundational in the fight against cancer and that such research can make a genuine global impact, benefiting patients far beyond the institution itself. Founded in 1851, The Royal Marsden in London is the world's first and most renowned cancer centers. It specialises in the diagnosis, treatment, and research of all types of cancer, with a highly experienced medical team and a dedicated department for paediatric and adolescent care. The hospital serves more than 50,000 patients annually and works in close collaboration with its academic partner, The Institute of Cancer Research, London, cementing its position as a global leader in cancer treatment innovation. Recent advancements enhancing cancer care Recent advancements at the CMP are enhancing cancer care and were reflected in a comprehensive report. The 'Marsden360' service, developed in partnership with Guardant Health, uses liquid biopsy (a blood test for cancer) to identify the genetic changes in DNA, allowing patients to be matched to targeted treatments. The testing was offered as part of an NHS England national study for patients with suspected late-stage lung cancer, as well as providing a commissioned NHS ctDNA service to guide treatment decisions for eligible patients with suspected late-stage breast cancer. The report also noted the Sharjah Clinical Genomics Laboratory is on track to become the first facility in the UK to offer fully automated genomic testing, with the capacity to conduct 5000 tests monthly. This is being achieved through collaboration with Automata, a global biotech company providing robotic automation solutions to the life sciences industry. The advancement has improved early detection of genetic mutations and enabled proactive care for high-risk cancer patients. Cutting-edge technology includes the Nanopore PromethION device for precise long-read DNA sequencing, already analyzing 110 whole genomes to yield new insights for treatment development. The CMP also plays a vital role in key clinical trials like 'ENABLE-NGS', 'PREVAIL', and 'ICED' (targeting leukemia, lung, and rare cancers), 'SIGNIFIED' (offering annual scans for Li-Fraumeni Syndrome), 'INOVATE' (blood-based monitoring for head/neck cancers), and 'RECUT Plus' (studying radiotherapy resistance). Further amplifying its impact, the lab contributed to over 24 peer-reviewed studies in 2024, presented at major conferences like ESMO and ASCO, exploring molecular profiling to redefine cancer risk and reshape treatment strategies. A UAE humanitarian vision for the world The Sharjah Clinical Genomics Laboratory reflects the UAE's vision of investing in human potential and scientific research, transforming humanitarian efforts into tangible impact in patients' lives. It serves as a prime example of successful collaboration between philanthropy and science, through which Sharjah has become an active partner and contributor to the future of genomic medicine worldwide. The laboratory's success in the UK exemplified the vision and commitment of Her Highness Sheikha Jawaher Al Qasimi commitment to supporting cancer patients. Her Highness's efforts have directly supported several specialised institutions such as Children's Cancer Hospital Egypt 57357, the Children's Cancer Center of Lebanon (CCCL), the National Cancer Institute in Egypt (Sheikha Jawaher Al Qasimi Building), and the Union for International Cancer Control's (UICC) Fund for Childhood Cancer Patients. Through these efforts, Her Highness Sheikha Jawaher Al Qasimi champions a UAE global humanitarian mission that transcends borders.
